Iovance Biotherapeutics, Inc. SEC filings IOVA
Iovance Biotherapeutics, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Oct 1, 2010. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 5, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 3 | Initial insider ownership | Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 6, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 28, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| S-8 | Employee stock plan registration | Jun 18, 2026 | — |
| S-8 | Employee stock plan registration | Jun 18, 2026 | — |
| S-3ASR | Automatic shelf registration | Jun 18, 2026 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 10, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | May 1, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 10, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 24, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 9, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Other events
|
Aug 29, 2025 | Aug 29, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 22, 2025 | Aug 22, 2025 |
| 424B5 | Prospectus supplement | Aug 22, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 19, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 3 | Initial insider ownership | Aug 8, 2025 | Aug 6, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 7, 2025 | Aug 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 15, 2025 | Jul 15, 2025 |
| 3 | Initial insider ownership | Jul 10, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 13, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Other events
|
Feb 10, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Jan 16, 2025 | Jan 14, 2025 |
| 4 | Insider transaction | Jan 16, 2025 | Jan 14, 2025 |
| 4 | Insider transaction | Jan 16, 2025 | Jan 14, 2025 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 16, 2024 |
| S-8 | Employee stock plan registration | Dec 13, 2024 | — |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 3 | Initial insider ownership | Dec 2, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 21, 2024 | Nov 15, 2024 |
| 4 | Insider transaction | Nov 14, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 8, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 18, 2024 | — |
| 4 | Insider transaction | Oct 16, 2024 | Oct 14, 2024 |
| 4 | Insider transaction | Oct 16, 2024 | Oct 14, 2024 |
| 4 | Insider transaction | Oct 16, 2024 | Oct 14, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 8, 2024 |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Other events
|
Jun 28, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Other events
|
Jun 3, 2024 | May 31, 2024 |
| 8-K |
Current report
Other events
|
May 24, 2024 | May 23, 2024 |
| DEFA14A | Additional proxy material | May 17, 2024 | — |
| S-8 | Employee stock plan registration | May 10, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | May 1, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Apr 17, 2024 | Apr 15, 2024 |
| 4 | Insider transaction | Apr 17, 2024 | Apr 15, 2024 |
| 4 | Insider transaction | Apr 17, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Other events
|
Apr 3, 2024 | Apr 3, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Mar 29, 2024 | Mar 26, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 19, 2024 | — |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IOVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Carlos, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1425205
- Former names
- Lion Biotechnologies, Inc. (until Jun 5, 2017); Genesis Biopharma, Inc (until Sep 23, 2013); FREIGHT MANAGEMENT CORP (until Mar 8, 2010)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.